A comprehensive genomic analysis of more than 200 mesothelioma tumor samples has identified previously unknown genetic mutations, including several that may prove to be actionable right now for diagnosis and treatment of the deadly lung cancer, researchers say. Raphael Bueno (Brigham and Women’s) is lead author of the study.
